Roche CEO Thomas Schinecker joins Bloomberg's "The Opening Trade" to discuss his company's earnings and the timeline for the potential launch for Roche's blockbuster breast cancer pill that may become one of the company's biggest sellers by the end of the year.
See omnystudio.com/listener for privacy information.
